Literature DB >> 268999

Adult acute leukemia: frequency of central system involvement in long term survivors.

I P Law, J Blom.   

Abstract

The incidence and frequency of CNS relapses in long term surviving adults, age eighteen and over, covering the period 1967-1972, were presented. Four of 20 patients with ANLL and 12 of 24 patients with ALL were demonstrated to have CNS leukemia during the course of their illness. The onset of neurologic manifestation in three of four ANLL patients with CNS leukemia was observed within three months of the diagnosis, whereas it was delayed to 6-12 months interval in eight of 12 ALL patients. CNS relapses, a major determinant for CNS prophylactic and maintenance therapy, were observed in 75% of the patients with ALL and none in ANLL patients who were treated with I.T. chemotherapy and cranial radiation of 2000 R. Therefore, our observation suggests that CNS prophylactic and maintenance therapy should be of value in adults with ALL as in children; whereas, in ANLL, further observation is warranted before any definite therapy can be advocated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268999     DOI: 10.1002/1097-0142(197709)40:3<1304::aid-cncr2820400346>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.

Authors:  Stephen M Akers; Heather A O'Leary; Fred L Minnear; Michael D Craig; Jeffrey A Vos; James E Coad; Laura F Gibson
Journal:  Exp Hematol       Date:  2010-05-12       Impact factor: 3.084

2.  Prolonged remission in Di Guglielmo's syndrome.

Authors:  R Carr; E M Innes
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

Review 3.  Meningeosis leukaemica in adult acute lymphoblastic leukaemia.

Authors:  N Gökbuget; D Hoelzer
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

4.  Experiences with the Ommaya reservoir for prophylaxis and treatment of the central nervous system in adult acute myelocytic leukemia.

Authors:  H Haaxma-Reiche; S Daenen; R J Witteveen
Journal:  Blut       Date:  1988-12

5.  Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.

Authors:  J C Scott-Moncrieff; T C Chan; M L Samuels; J R Cook; G L Coppoc; D B DeNicola; R C Richardson
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.